Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 566, pseudogene (RNU6-566P) is a human non-coding RNA classified as a pseudogene related to the highly conserved U6 small nuclear RNA (snRNA) family. Functional U6 snRNA is a key catalytic component of the spliceosome, essential for pre-mRNA intron removal during splicing, but pseudogenes like RNU6-566P do not code for a functional product and do not directly participate in the spliceosome or have a defined biological activity[1][3]. While some pseudogenes can regulate gene expression or serve as competing endogenous RNAs, most U6 pseudogenes—including RNU6-566P—lack experimental evidence for such a function and are generally considered non-functional genomic elements[2][3]. Therefore, this entry is not a classical drug or therapeutic target, nor is it a receptor, enzyme, transporter, or similar protein class. It is a non-functional RNA gene fragment, and its inclusion as a research or drug target is likely incorrect. Key points: - RNU6-566P is a pseudogene and not a protein, enzyme, receptor, or druggable target[3]. - U6 snRNA is functional and essential; its pseudogenes are essentially genomic relics without known activity[3]. - No evidence supports a direct role for RNU6-566P in disease, drug interaction, or as a biomarker. - Its main classification is "Other" for both molecular class and biological role, due to pseudogene status. If your intent was to query a **functional U6 snRNA** or a **spliceosomal target**, please specify, as RNU6-566P is not a drug target or receptor. If you expect a different molecule, the entry may be **incorrect** for your use-case[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 566, pseudogene (RNU6-566P).